微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -4.96% | -43.35% | 89.7% | 141/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | -48.15% | -91.83% | -404.72% | 141/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | -9.54% | 22.75% | -26.36% | 133/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | -7.55% | 14.5% | -118.21% | 136/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | -3.46% | 8.22% | 86.22% | 134/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | -25.1% | -145.84% | -103.24% | 135/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | -12.35% | -170.83% | -39.86% | 138/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | -8.83% | -379.89% | -134.22% | 138/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | -3.77% | -26.94% | 63.08% | 135/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | -10.21% | -613.07% | -123.9% | 125/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | -4.56% | -437.78% | -147.83% | 124/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | -1.84% | -306.74% | 38.05% | 119/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | -2.97% | -621.05% | -249.25% | 131/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | 1.99% | -57.11% | 47.41% | 97/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | 1.35% | -74.53% | 51.69% | 101/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | 0.89% | -62.45% | 56.14% | 103/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | 0.57% | -43% | -87.72% | 105/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | 4.64% | 52.13% | -12.45% | 80/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | 5.3% | 11.81% | 123.63% | 77/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | 2.37% | 29.51% | 137% | 91/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2021-03-31 | 1% | 171.94% | -67.21% | 92/157 | 2.49% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-12-31 | 3.05% | -45.24% | -35.65% | 96/157 | 3.8% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-09-30 | 4.74% | -57.9% | 159.02% | 73/157 | 3.13% | 哈三联 | 27.17% | 行业排名> |
| 2020-06-30 | 1.83% | -72.06% | 231.65% | 90/157 | 4.28% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-03-31 | -1.39% | -140.64% | -124.96% | 98/157 | 2.23% | 中哲精化 | 45.32% | 行业排名> |
| 2019-12-31 | 5.57% | -72.43% | -50.53% | 81/157 | 2.57% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-09-30 | 11.26% | -30.79% | 71.91% | 25/157 | 7.58% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-06-30 | 6.55% | -52.88% | 91.52% | 32/157 | 5.02% | 奥赛康 | 35% | 行业排名> |
| 2019-03-31 | 3.42% | -67.61% | -83.07% | 30/157 | 2.45% | 奥赛康 | 28.15% | 行业排名> |
| 2018-12-31 | 20.2% | 25.94% | 24.15% | 13/157 | 7.16% | 宏源药业 | 21.91% | 行业排名> |
| 2018-09-30 | 16.27% | 46.84% | 17.05% | 6/157 | 7.21% | 奥赛康 | 9.7% | 行业排名> |
| 2018-06-30 | 13.9% | 89.89% | 31.63% | 3/157 | 4.63% | 奥赛康 | 40.69% | 行业排名> |
| 2018-03-31 | 10.56% | 126.61% | -34.16% | 2/157 | 2.57% | 信立泰 | 25.93% | 行业排名> |
| 2017-12-31 | 16.04% | -34.8% | 44.77% | 19/157 | 9.62% | 昂利康 | 15.91% | 行业排名> |
| 2017-09-30 | 11.08% | -48.99% | 51.37% | 21/157 | 8.31% | 奥赛康 | 12.08% | 行业排名> |
| 2017-06-30 | 7.32% | -30.81% | 57.08% | 24/157 | 5.56% | 一品红 | 31.62% | 行业排名> |
| 2017-03-31 | 4.66% | 5.91% | -81.06% | 8/157 | 2.1% | 丽珠集团 | 49.43% | 行业排名> |
| 2016-12-31 | 24.6% | 443.05% | 13.26% | 11/157 | 6.05% | 中哲精化 | 54.24% | 行业排名> |
| 2016-09-30 | 21.72% | 640.3% | 105.29% | 4/157 | 5.64% | 华东医药 | 7.2% | 行业排名> |
| 2016-06-30 | 10.58% | 319.96% | 140.45% | 11/157 | 3.52% | ST南新 | 81.7% | 行业排名> |
| 2016-03-31 | 4.4% | 578.26% | -2.87% | 15/157 | 2.69% | 德展健康 | 29.5% | 行业排名> |